UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008488
Receipt number R000009975
Scientific Title a study relating to the utility of contrast enhanced EUS with sonazoid for diagnose of hepato-pancreato-biliary disease.
Date of disclosure of the study information 2012/07/20
Last modified on 2015/07/21 08:53:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

a study relating to the utility of contrast enhanced EUS with sonazoid for diagnose of hepato-pancreato-biliary disease.

Acronym

a study relating to the utility of contrast enhanced EUS with sonazoid for diagnose of hepato-pancreato-biliary disease

Scientific Title

a study relating to the utility of contrast enhanced EUS with sonazoid for diagnose of hepato-pancreato-biliary disease.

Scientific Title:Acronym

a study relating to the utility of contrast enhanced EUS with sonazoid for diagnose of hepato-pancreato-biliary disease

Region

Japan


Condition

Condition

All indication cases for ceEUS

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

to assess the efficacy of sonazoid ce-EUS in the diagnose of hepato-pancreato-biliary disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

diagnostic capability

Key secondary outcomes

Lesion detectability, amounts of medicine


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

sonazoid 0.01ml/Kg

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All indication cases for ce-EUS

Key exclusion criteria

Patients without written informed consent

Patients with severely impaired organ
function

Patients considered ineligible for this study

Patients with allergy for sonazoid

Patients with allergy for egg

Patients with possibility of pregnant

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ashida Reiko

Organization

Osaka Prefectural Hospital Organization
Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Departments of Cancer Survey and Gastrointestinal Oncology

Zip code


Address

1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan

TEL

06-6972-1181

Email

asida-re@mc.pref.osaka.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ashida Reiko

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Departments of Cancer Survey and Gastrointestinal Oncology

Zip code


Address

1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan

TEL

06-6972-1181

Homepage URL


Email

asida-re@mc.pref.osaka.jp


Sponsor or person

Institute

Osaka Medical Center for Cancer and Cardiovascular Diseases
Departments of Cancer Survey and Gastrointestinal Oncology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府立成人病センター


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 02 Month 02 Day

Date of IRB


Anticipated trial start date

2012 Year 02 Month 02 Day

Last follow-up date

2014 Year 11 Month 30 Day

Date of closure to data entry

2014 Year 11 Month 30 Day

Date trial data considered complete

2014 Year 11 Month 30 Day

Date analysis concluded

2015 Year 11 Month 30 Day


Other

Other related information



Management information

Registered date

2012 Year 07 Month 20 Day

Last modified on

2015 Year 07 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009975


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name